Switzerland's State Secretary for Education, Research and Innovation, Dr Mauro Dell'Ambrogio, has signed the ELIXIR Consortium Agreement for the establishment of ELIXIR, the European Life science Infrastructure for Biological Information. This brings closer the time when five Member States will have signed, and the Consortium Agreement will enter into force. The Swiss government has committed to investing 35 million over the four-year period from 2013 to 2016. This monetary contribution is mainly provided through financial support to SIB Swiss Institute of Bioinformatics the Swiss ELIXIR Node. However, the experience and expertise of SIB are also an important part of Switzerland's participation. Access to SIB's bioinformatics core resources and many other high-quality services, as well as the benefit of its solid experience in bioinformatics training will be major assets in the launch and success of ELIXIR.
The deluge of data produced by life science researchers thanks to new-generation technologies is a very positive development, given the wealth of information hidden in this data. Our society is constantly being challenged by crucial questions related to food, energy, the environment and, of course, health. Such data is a windfall for researchers provided that both the information and the bioinformatics resources for its analysis are accessible over the long term. ELIXIR is the European consortium, whose aim is to set up and operate a sustainable European infrastructure for biological information to support life science research and its translation to medicine, the environment, the bio-industries and society. This requires international coordination and the assurance of long-term funding.
The International Consortium Agreement signed by Switzerland today is key for the set-up of ELIXIR. Niklas Blomberg, Director of ELIXIR, is "very pleased that Switzerland, a pioneer and one of the world leaders in bioinformatics, is one of the first Memb
|Contact: Irene Perovsek|
Swiss Institute of Bioinformatics